Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ephraim J Fuchs

Showing results (31-40 of 113) with videos related to

Pageof 12
Sort By:
Blood|October 31, 2002
Successful therapy of metastatic cancer using tumor vaccines in mixed allogeneic bone marrow chimerasLeo Luznik, Jill E Slansky, Sanju Jalla, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 2, 2009
Cyclophosphamide unmasks an antimetastatic effect of local tumor cryoablationMoshe Yair Levy, Abhinav Sidana, Wasim H Chowdhury, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 19, 2010
5-azacytidine as salvage treatment in relapsed myeloid tumors after allogeneic bone marrow transplantationJavier Bolaños-Meade, B Douglas Smith, Steven D Gore, et al.
Blood|September 8, 2012
HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell diseaseJavier Bolaños-Meade, Ephraim J Fuchs, Leo Luznik, et al.
Cancer Research|May 20, 2004
The HMG-I oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemiaYi Xu, Takita Felder Sumter, Raka Bhattacharya, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 16, 2008
The allogeneic effect revisited: exogenous help for endogenous, tumor-specific T cellsHeather J Symons, Moshe Y Levy, Jie Wang, et al.
Transplantation and Cellular Therapy|July 17, 2021
Engraftment of Double Cord Blood Transplantation after Nonmyeloablative Conditioning with Escalated Total Body Irradiation Dosing to Facilitate Engraftment in Immunocompetent PatientsClaudio G Brunstein, Todd E DeFor, Ephraim J Fuchs, et al.
Science Translational Medicine|November 15, 2013
Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamideChristopher G Kanakry, Sudipto Ganguly, Marianna Zahurak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 29, 2013
Partially mismatched transplantation and human leukocyte antigen donor-specific antibodiesDouglas E Gladstone, Andrea A Zachary, Ephraim J Fuchs, et al.
Transplantation and Cellular Therapy|April 29, 2023
Cost-Effectiveness of Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Bone Marrow Transplantation: Evidence from BMT CTN 1101Scott D Ramsey, Aasthaa Bansal, Lily Li, et al.
Pageof 12

Showing results (31-40 of 113) with videos related to

Sort By:
Pageof 12
Blood|October 31, 2002
Successful therapy of metastatic cancer using tumor vaccines in mixed allogeneic bone marrow chimerasLeo Luznik, Jill E Slansky, Sanju Jalla, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 2, 2009
Cyclophosphamide unmasks an antimetastatic effect of local tumor cryoablationMoshe Yair Levy, Abhinav Sidana, Wasim H Chowdhury, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 19, 2010
5-azacytidine as salvage treatment in relapsed myeloid tumors after allogeneic bone marrow transplantationJavier Bolaños-Meade, B Douglas Smith, Steven D Gore, et al.
Blood|September 8, 2012
HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell diseaseJavier Bolaños-Meade, Ephraim J Fuchs, Leo Luznik, et al.
Cancer Research|May 20, 2004
The HMG-I oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemiaYi Xu, Takita Felder Sumter, Raka Bhattacharya, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 16, 2008
The allogeneic effect revisited: exogenous help for endogenous, tumor-specific T cellsHeather J Symons, Moshe Y Levy, Jie Wang, et al.
Transplantation and Cellular Therapy|July 17, 2021
Engraftment of Double Cord Blood Transplantation after Nonmyeloablative Conditioning with Escalated Total Body Irradiation Dosing to Facilitate Engraftment in Immunocompetent PatientsClaudio G Brunstein, Todd E DeFor, Ephraim J Fuchs, et al.
Science Translational Medicine|November 15, 2013
Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamideChristopher G Kanakry, Sudipto Ganguly, Marianna Zahurak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 29, 2013
Partially mismatched transplantation and human leukocyte antigen donor-specific antibodiesDouglas E Gladstone, Andrea A Zachary, Ephraim J Fuchs, et al.
Transplantation and Cellular Therapy|April 29, 2023
Cost-Effectiveness of Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Bone Marrow Transplantation: Evidence from BMT CTN 1101Scott D Ramsey, Aasthaa Bansal, Lily Li, et al.
Pageof 12